Essential Hypertension Treatment in Adults with Type 2 Diabetes

Adults who have both Type 2 diabetes and essential hypertension require a specific evidence-based approach to blood pressure management — one that accounts for this comorbidity when setting treatment thresholds, targets, and agent selection.

Clinical Scenario

This protocol applies to adults with Type 2 diabetes and essential hypertension. The presence of Type 2 diabetes directly shapes when antihypertensive drug treatment should begin and what blood pressure goals to pursue.

Blood Pressure Targets

SBP goal <130 mm Hg (encourage <120 mm Hg)
DBP goal <80 mm Hg

Treatment Approach (partial overview)

The protocol specifies the systolic and diastolic initiation thresholds for drug therapy and guides selection among first-line antihypertensive classes — with distinct recommendations when chronic kidney disease or albuminuria is present. The complete regimen and sequencing are in the full protocol.

Instant Access to Structured Evidence-Based Regimens

References

DOI: 10.1161/CIR.0000000000001356

In adults with T2D and hypertension, antihypertensive drug treatment should be initiated at an SBP of ≥130 mm Hg with a treatment goal of <130 mm Hg, with encouragement to achieve an SBP <120 mm Hg to reduce CVD morbidity and mortality.

In adults with T2D and hypertension, antihypertensive drug treatment should be initiated at a DBP of ≥80 mm Hg with a treatment goal of <80 mm Hg to reduce CVD morbidity and mortality.

In adults with T2D and hypertension, all first-line classes of antihypertensive agents (ie, thiazide-type diuretics, long-acting CCB, ACEi, and ARB) are useful and effective for BP lowering.

In adults with diabetes and hypertension, ACEi or ARB are recommended in the presence of CKD as identified by eGFR <60 mL/min/1.73 m² or albuminuria ≥30 mg/g and should be considered when mild albuminuria (<30 mg/g) is present to delay progression of diabetes-related kidney disease.

View source ↗